V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough

Accendra Health Executive Compensation (FY25)

ACH · Executive and director compensation, fiscal 2023 to 2025

The Accendra Health brief, $1,500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $1,200 for the board report; $2,400 for both.
Data as of September 20, 2026Latest filing (8-K): May 15, 2026
13 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Accendra Health brief$1,500Get the executive brief
262 figures on this page: 252 cited to the filing that reported them, 10 calculated from figures it prints. See the citations
Chief executive, fiscal 2025
◇
Edward Pesicka
Latest say-on-pay support
=
May 14, 2026
Chief executive pay ratio
◇
To the median employee
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Edward Pesicka: $10,737,904 → $11,157,809 (3.9% higher)
CEO pay ratio: 266:1 → 272:1 (2.3% higher)

Frequently asked questions

Answers drawn from the data on this page.
Who is Accendra Health's chief executive and what were they paid?
Edward Pesicka was paid $11,157,809 in total compensation as President & Chief Executive Officer for fiscal 2025. Compared with the $10,737,904 reported for fiscal 2024, Pesicka's total was 3.9% higher.
What was Accendra Health's say-on-pay result?
Shareholders supported the say-on-pay proposal with 91.9% of votes cast including abstentions in favor at the meeting held May 14, 2026 for fiscal 2025.
Which companies are in Accendra Health's peer group?
The disclosed peer group includes AdaptHealth Corp., Baxter International Inc., Boston Scientific Corporation, C.H. Robinson Worldwide, Inc. and DENTSPLY SIRONA Inc., among others.
What is Accendra Health's chief executive pay ratio?
The disclosed chief executive pay ratio for fiscal 2025 is 272:1, against median employee compensation of $41,005.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Edward Pesicka
President & Chief Executive Officer
◇—◇—◇—◇◇
Andrew Long
Executive Vice President, Chief Executive Officer, Products & Healthcare Services
◇—◇—◇—◇◇
Perry Bernocchi
Executive Vice President, Chief Operating Officer
◇—◇—◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Edward Pesicka
President & Chief Executive Officer
◇—◇—◇—◇◇
Andrew Long
Executive Vice President, Chief Executive Officer, Products & Healthcare Services
◇—◇—◇—◇◇
Perry Bernocchi
Executive Vice President, Chief Operating Officer
◇—◇—◇—◇◇
Jonathan Leon
Executive Vice President & Chief Financial Officer
◇—◇—◇—◇◇
Heath Galloway
Executive Vice President, General Counsel & Corporate Secretary
◇—◇—◇—◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Edward Pesicka
President & Chief Executive Officer
◇—◇—◇—◇◇
Andrew Long
Executive Vice President, Chief Executive Officer, Products & Healthcare Services
◇—◇———◇◇
Perry Bernocchi
Executive Vice President, Chief Operating Officer
◇—◇—◇—◇◇
Jonathan Leon
Executive Vice President & Chief Financial Officer
◇◇◇———◇◇
Heath Galloway
Executive Vice President, General Counsel & Corporate Secretary
◇◇◇———◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Andrew G. LongRSU◇——◇——◇
Andrew G. LongPSU◇◇◇—◇—◇
Edward A. PesickaRSU◇——◇——◇
Edward A. PesickaPSU◇◇◇—◇—◇
Heath H. GallowayPSU◇◇◇—◇—◇
Heath H. GallowayRSU◇——◇——◇
Jonathan A. LeonRSU◇——◇——◇
Jonathan A. LeonPSU◇◇◇—◇—◇
Perry A. BernocchiRSU◇——◇——◇
Perry A. BernocchiPSU◇◇◇—◇—◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Edward PesickaPSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
Andrew LongPSU◇◇——
RSU◇◇——
RSU◇◇——
PSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
Perry BernocchiPSU◇◇——
RSU◇◇——
RSU◇◇——
PSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
Jonathan LeonRSU◇◇——
PSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
PSU◇◇——
PSU◇◇——
Heath GallowayRSU◇◇——
RSU◇◇——
PSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Mark A. Beck
Board chair
◇◇————◇
Stephen W. Klemash
◇◇————◇
Gwendolyn M. Bingham
◇◇————◇
Kenneth Gardner-Smith
◇◇————◇
Robert J. Henkel
◇◇————◇
Teresa L. Kline
◇◇————◇
Rita F. Johnson-Mills
◇◇————◇
Carissa L. Rollins
◇◇————◇
Edward A. Pesicka served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Board chair premium◇
Audit committee chair◇
Compensation committee chair◇
Nominating and governance chair◇
Equity is delivered as restricted stock units.

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • AdaptHealth Corp. AHCO
  • Baxter International Inc. BAX
  • Boston Scientific Corporation BSX
  • C.H. Robinson Worldwide, Inc. CHRW
  • DENTSPLY SIRONA Inc. XRAY
  • Henry Schein, Inc. HSIC
  • Hologic, Inc. HOLX
  • Patterson Companies, Inc. PDCO
  • Quest Diagnostics Incorporated DGX
  • ResMed Inc. RMD
  • Select Medical Holdings Corporation SEM
  • STERIS plc STE
  • WESCO International, Inc. WCC
  • Zimmer Biomet Holdings, Inc. ZBH

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025May 14, 2026=◇◇◇
2024May 15, 2025=◇◇◇
2023May 9, 2024=◇◇◇
2022May 11, 2023=◇◇◇
2021April 29, 2022=◇◇◇
2020April 29, 2021=◇◇◇
2019May 1, 2020=◇◇◇
2018May 10, 2019=◇◇◇
2017May 8, 2018=◇◇◇
2016May 5, 2017=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
Email me this page as a cited PDF
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when Accendra Health files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Accendra Health disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Accendra Health sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for a Velarion Pro seat
Full platform access for one person: every industry we cover, peer positioning, and the written analysis. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.
Join the list for Peer Group Review
Whether Accendra Health's disclosed peer group is defensible, who names Accendra Health back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
262 figures on this page: 252 cited to the filing that reported them, 10 calculated from figures it prints.
252 cited to the filing
10 calculated from the filing

Documents cited

  1. 0001104659-26-061888
    Item 5.07 Submission of Matters to a Vote of Security Holders
  2. 0001104659-26-038823
    2025 Grants of Plan-Based Awards · 2025 Summary Compensation Table · CEO Pay Ratio · Director Compensation · and 1 more section
  3. 0001558370-25-007927
    Item 5.07 Submission of Matters to a Vote of Security Holders
  4. 0001193125-25-072752
    2024 Summary Compensation Table
  5. 0001558370-24-007697
    Item 5.07 Submission of Matters to a Vote of Security Holders
  6. 0001193125-24-078804
    2023 Summary Compensation Table
  7. 0000075252-23-000031
    Item 5.07 Submission of Matters to a Vote of Security Holders
  8. 0000075252-22-000024
    Item 5.07 Submission of Matters to a Vote of Security Holders
  9. 0000075252-21-000079
    Item 5.07 Submission of Matters to a Vote of Security Holders
  10. 0000075252-20-000051
  11. 0000075252-19-000077
  12. 0000075252-18-000069
  13. 0000075252-17-000075
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Accendra Health executive compensation, FY2023–FY2025.” https://intel.velarion.ai/comp/ACH (accessed 2026).
Short form: data: Velarion

The Accendra Health brief, $1,500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $1,200 for the board report; $2,400 for both.
Get the executive briefGet the board briefNo account needed.
13 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Accendra Health and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

Peers Accendra Health discloses

The companies named in ACH's own disclosed peer group.

AdaptHealth Corp.Baxter International Inc.Boston Scientific CorporationC.H. Robinson Worldwide, Inc.DENTSPLY SIRONA Inc.Henry Schein, Inc.Hologic, Inc.Patterson Companies, Inc.Quest Diagnostics IncorporatedResMed Inc.Select Medical Holdings CorporationSTERIS plcWESCO International, Inc.Zimmer Biomet Holdings, Inc.

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  All companies · The Pay Desk · Methodology · Terms · Privacy